- €5.31bn
- €6.79bn
- €16.01bn
- 44
- 95
- 61
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | Interim Report | PRESS |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 16,655 | 17,112 | 17,792 | 16,627 | 16,011 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15,942 | 16,633 | 16,997 | 18,193 | 14,647 |
Operating Profit | 713 | 479 | 795 | -1,566 | 1,364 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 569 | 336 | 663 | -1,666 | 1,252 |
Provision for Income Taxes | |||||
Net Income After Taxes | 422 | 230 | 456 | -1,383 | 808 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 422 | 234 | 456 | -1,382 | 810 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 422 | 234 | 456 | -1,383 | 812 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.41 | 1.47 | 2.53 | -7.36 | 5.07 |
Dividends per Share |